Milasen | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

38 results for “Milasen”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

300 participants · First posted Jul 27, 2023

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

39 participants · First posted Jun 21, 2024

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

252 participants · First posted Mar 19, 2018

Not yet recruiting

Hepatitis B and C Within the Chinese Community in Milan

1,000 participants · First posted Nov 21, 2025

Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

436 participants · First posted May 15, 2014

TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial

110 participants · First posted Aug 17, 2018

Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan

400 participants · First posted Nov 8, 2011

Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation

59 participants · First posted Jul 27, 2022

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

220 participants · First posted Nov 6, 2007

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

24 participants · First posted Jan 11, 2022

Page 1 of 3